Tourmaline Bio Total Risk Alpha
| TRMLDelisted Stock | | | 47.98 0.00 0.00% |
Reference data associated with the Total Risk Alpha technical indicator for Tourmaline Bio. Coverage may vary across instruments due to feed availability.
Tourmaline Bio has current Total Risk Alpha of 1.68. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 1.68 | |
| ER[a] | = | Expected return on investing in Tourmaline Bio |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Tourmaline Bio |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
Tourmaline Bio sits atop the peer group for total risk alpha within its peer group. It is currently under evaluation for maximum drawdown within its peer group where Maximum Drawdown runs almost
34.85 per Total Risk Alpha. Tourmaline Bio's Maximum Drawdown registers at
34.85 relative to Total Risk Alpha
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Other Technical Indicators